Dear Editor,
The tropical plant Madagascar periwinkle Catharanthus roseus (L.) G.Don is a rich source of plant-derived medicinal terpenoid indole alkaloids (TIAs), including the anti-hypertensive ajmalicine, the sedative compound serpentine, and the anticancer drugs vinblastine and vincristine. However, the latter two compounds are produced in C. roseus plants only in very low amounts. Elicitors such as hormones (e.g. jasmonates or salicylic acid) activate plant natural defense responses, including increased secondary metabolite production (El-Sayed and Verpoorte, 2007; Lackman et al., 2011) . There are two different metabolic pathways for the biosynthesis of terpenoids leading to the formation of the C 5 central precursor isopentenyl diphosphate (IPP), namely the classical cytosolic mevalonate pathway and the mevalonate-independent plastidic 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway. The biosynthesis of C. roseus TIAs starts with the condensation of tryptamine (shikimate pathway) and secologanin (MEP pathway) to form the key intermediate strictosidine, the common backbone structure of all TIAs. However, to our knowledge, the late steps of the alkaloid pathway in C. roseus and the genes involved remain partly unknown (Rischer et al., 2006) . When there is a high demand for the product and only low levels accumulate in plants, plant cell cultures have shown to be an alternative production system of valuable secondary metabolites offering controlled conditions on a large scale for the rapid reproduction of plant cells without the need for depleting natural sources (Oksman-Caldentey and Inzé, 2004) . Metabolic flux analysis using 13 C-labeled substrates is essential for understanding the control and regulation of metabolic networks, and it has been often observed that significant changes in C-flow are sometimes associated with only small adjustments in metabolite abundance (Ratcliffe and Shachar-Hill, 2006; Baxter et al., 2007) . Whilst transgenic lines, which are one prerequisite for this approach, are available for a multitude pathways of secondary metabolism, methods for assessing metabolic fluxes, which are another prerequisite, are largely not. In this study, we performed a 13 C-stable isotope feeding experiment using [ 13 C 3 ]-pyruvate as substrate. Given that mass spectrometry does not distinguish atomic level resolution, [ 13 C 3 ]-pyruvate was introduced into the network for enhanced sensitivity, and the labeling pattern of metabolites was subsequently measured using two complementary techniques: gas chromatography coupled to time-of-flight-mass spectrometry (GC-TOF-MS) (Lisec et al., 2006; Huege et al., 2011; Kopka et al., 2005; Luedemann et al., 2008) and ultra-performance liquid chromatography coupled to high-resolution Fourier Transform mass spectrometry (UPLC-FT-MS) (Giavalisco et al., 2009; Tohge and Fernie, 2010) . High-resolution UPLC-FT-MS analysis was used for the target analysis of the secondary metabolites and TIA precursors loganic acid, loganin, and secologanin, and also the TIA ajmalicine, not detectable by GC-TOF-MS, which were here rather used to assess the importance of primary metabolite precursor supply to these pathways. Catharanthus roseus cell extracts treated for 24 h with methyl jasmonate (MeJA) or dimethyl sulfoxide (DMSO/ control) and harvested at different time points (0, 1, 4, 8, and 24 h) were first analyzed for their metabolite composition using GC-TOF-MS (Supplemental Table 1 , no addition of 13 C-labeled substrate). Supplemental Table 1 shows the steady-state relative levels of all measurable metabolites (53 metabolites) in C. roseus cell extracts. Significant accumulation (t-test p < 0.05) of maltose, trehalose, galactinol, glucose-6-phosphate, alanine, glutamate, tyrosine, histidine, γ-amino butyric acid (GABA), urea, succinate, ascorbate, and threonate was observed in C. roseus cells after 4 h of MeJA elicitation. Only phenylalanine was shown to significantly decrease after 8 h of MeJA elicitation (t-test p < 0.05). From the total primary metabolites detected, only 15% were shown to increase after 4 h of MeJA treatment, 2% decreased, whereas the majority of metabolites (83%) remained unchanged, suggesting that the levels of primary metabolites in C. roseus cells were largely not affected by MeJA/DMSO treatment.
We next determined the fate of 13 C-label accumulated in primary metabolites using GC-TOF-MS and the fate of 13 C-label accumulated in secondary metabolites using UPLC-FT-MS following incubation in [ 13 C 3 ]-pyruvate for a period of 48 h ( Figure 1A and Supplemental Tables 2 and 3) . Catharanthus roseus cells were treated with MeJA/DMSO 24 h before being incubated in [ 13 C 3 ]-pyruvate, and cells were harvested at different time points (0, 4, 8, 24 , and 48 h). Label accumulation was observed in 10 primary metabolites, namely the amino acids alanine, valine, aspartate, glutamate, proline, GABA, and the TCA cycle intermediates 2-oxo-glutarate, succinate, fumarate, and malate ( Figure 1B and Supplemental Tables 2 and 3) . Although there were no significant changes between MeJA/DMSO treatments, a lower enrichment was observed in MeJA-treated cells, and this observation is particularly evident at 8 and 24 h. This suggests that the fluxes to the TCA cycle and to compounds like glutamate, proline, and GABA have been more activated upon disturbance during this period of time, until cells reached again a balance/homeostasis which is apparent at 48 h when MeJA-treated cells reach similar DMSO control levels. Incubation in [ 13 C 3 ]-pyruvate revealed an increased incorporation of 13 C through time in all measurable metabolites in both treatments, except for pyruvate, which was observed to decrease after 8 h incubation in both MeJA/DMSO samples, suggesting that this substrate is being used for the production of secondary metabolites of the plastidic monoterpene iridoid pathway.
UPLC-FT-MS analysis of secondary metabolites meanwhile revealed that only loganic acid could be detected, as it accumulated significantly (t-test p < 0.05) in MeJA elicited C. roseus cell cultures with respect to DMSO control after 24 h of MeJA elicitation (Figure 1B and Supplemental  Tables 2 and 3 ) and its production was demonstrated, as indicated by accumulation of 13 C label following incubation in [ 13 C 3 ]-pyruvate, to be considerably greater following elicitation than in the control samples. When taken together, the results of this experiment demonstrate (1) that the production of the key intermediate loganic acid does not appear to be constrained by the supply of precursors from primary metabolism and (2) that combined metabolite profiling strategies coupled to stable isotope labeling proves to be an effective way to monitor C-flow from primary into specialized metabolism. Although such experiments have previously been carried out for evaluating the flux from phenylalanine into phenylalanine-derived volatiles (Tieman et al., 2006) , not many studies have demonstrated its utility in assessing the capacity of producing high-value natural products in a cell suspension system. Our study will likely be a highly useful tool for assessing the promise of future metabolic engineering and synthetic biology strategies. It is also anticipated that this study will represent an important foundation on which to develop even more sensitive methodologies which will be capable of dissecting the rates of flux through individual reactions within the intricate pathways of plant-specialized metabolism.
